Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 4/2005

01-04-2005 | Letters

Comment

to: Borch-Johnsen K, Colagiuri S, Balkau B et al (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396–1402

Authors: B. Balkau, T. Hillier, E. Vierron, A. D’Hour, P. Lépinay, B. Royer, C. Born

Published in: Diabetologia | Issue 4/2005

Login to get access

Excerpt

To the Editor: The DETECT-2 group [1] recently described the pandemic of prevalent pre-diabetes that will occur with adoption of the new American Diabetes Association (ADA) criteria for IFG [2], leading to a more than three-fold increase in prevalence. The aim of this note is to determine if this newly identified IFG group has a rate of incident diabetes that would support such a change, following on from a report in Singapore [3]. …
Literature
1.
Borch-Johnsen K, Colagiuri S, Balkau B et al (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396–1402CrossRefPubMed
2.
Genuth S, Alberti KG, Bennett P et al (2003) Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167PubMed
3.
Tai ES, Goh SY, Lee JJ et al (2004) Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care 27:1728–1734PubMed
4.
Barrett-Connor E (1980) The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycaemia. Am J Epidemiol 111:705–712
5.
Ricordeau P, Weill A, Vallier N, Bourrel R, Fender P, Allemand H (2000) L’épidemiologie du diabète en France metropolitaine. Diabetes Metab 26 (Suppl 6):11–24
6.
Gourdy P, Ruidavets JB, Ferrieres J et al (2001) Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions—the MONICA study 1995–97. Diabetes Metab 27:347–358
7.
DECODE Study Group (2003) Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 26:61–69
8.
Soderberg S, Zimmet P, Tuomilehto J et al (2004) High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. J Intern Med 256:37–47CrossRef
Metadata
Title
Comment
to: Borch-Johnsen K, Colagiuri S, Balkau B et al (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396–1402
Authors
B. Balkau
T. Hillier
E. Vierron
A. D’Hour
P. Lépinay
B. Royer
C. Born
Publication date
01-04-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1695-5

Other articles of this Issue 4/2005

Diabetologia 4/2005 Go to the issue

Article

A novel functional polymorphism (−336A/G) in the promoter of the partitioning-defective protein-6α gene is associated with increased glucose tolerance and lower concentrations of serum non-esterified fatty acids

Article

Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels

For debate

Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

Short communication

Delayed autoregulation of glucose transport in vascular endothelial cells

Article

Efficient restricted gene expression in beta cells by lentivirus-mediated gene transfer into pancreatic stem/progenitor cells

EASD

EASD News Section April 2005
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits